- Via its 510k process, the FDA approves Alere's (ALR +1.9%) i Influenza A&B diagnostic test, the only molecular test that can detect and differentiate the influenza A and B virus in less than 15 minutes. The product was launched in Europe earlier this year.
- The firm has rapid molecular tests in development for Strep A, C. difficile, RSV and chlamyida/gonorrhea.
From other sites
at CNBC.com (Sep 15, 2014)
at CNBC.com (Jul 23, 2013)
at CNBC.com (May 20, 2011)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs